Arthritis, Musculoskeletal and Skin Diseases Research in Connecticut
Arthritis, Musculoskeletal and Skin Diseases Research (93.846) awarded $96.0 million to recipients in Connecticut in 97 grants from fiscal 2021 to 2025, 3.6% of the program's national total. Yale Univ received the most, $58.9 million.
- Awarded in Connecticut$96.0 million
- Awards97
- Share of the program3.6%
- Rank among states7th of 44
- National total$2.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 48 | $16.2 million |
| FY 2022 | 60 | $22.6 million |
| FY 2023 | 57 | $20.0 million |
| FY 2024 | 49 | $18.2 million |
| FY 2025 | 51 | $18.9 million |
Recipients in Connecticut
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Yale Univ | Colleges and universities | 52 | $58.9 million |
| University of Connecticut Health Center | Colleges and universities | 29 | $26.5 million |
| University of Connecticut Health Center | Colleges and universities | 10 | $6.0 million |
| Myofinity Biosciences Inc | Small businesses | 3 | $2.0 million |
| Wesleyan University | Colleges and universities | 1 | $1.8 million |
| Connecticut Children's Medical Center | Nonprofits | 1 | $444,312 |
| Inprint Bio LLC | Small businesses | 1 | $295,481 |
Open opportunities under this program
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
See all 60 on the program page
Questions people ask
How much Arthritis, Musculoskeletal and Skin Diseases Research money goes to Connecticut?
$96.0 million from fiscal 2021 to 2025, across 97 awards. Connecticut ranks 7th of 44 states and territories for this program.
Who receives Arthritis, Musculoskeletal and Skin Diseases Research money in Connecticut?
The largest recipient is Yale Univ, with $58.9 million in 52 awards. Next are University of Connecticut Health Center and University of Connecticut Health Center.
Can organizations in Connecticut apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Arthritis, Musculoskeletal and Skin Diseases Research in other states
Other large programs in Connecticut
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Temporary Assistance for Needy Families
- National School Lunch Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- USAID Foreign Assistance for Programs Overseas
- Special Education Grants to States
- Title I Grants to Local Educational Agencies